Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Zytaze®, A Nutritional Supplement Proven to Enhance Botulinum Toxin Injections, Now Available Online At www.zytaze.com

November 27, 2012

ROSENBERG, Texas, Nov. 27, 2012 /PRNewswire/ — Due to increased demand for better, longer-lasting botulinum toxin results, OCuSOFT, Inc., an ophthalmic pharmaceutical research, development, and supply company is pleased to announce the immediate availability of Zytaze® to patients online at www.zytaze.com.

Zytaze®, recently mentioned as part of the “11 Hottest Celebrity Skin Treatments” by allure.com(1), provides nutritional support to enhance and prolong the effectiveness of botulinum toxin injections. Developed by Houston ophthalmic plastic and reconstructive surgeon, Dr. Charles Soparkar, Zytaze® contains a patent-pending blend of organic zinc and phytase, an enzyme that aids zinc absorption, to improve and extend the duration of results by as much as 30% on average(2). Physicians have reported that patients who previously shied away from cosmetic injections are now coming in due to lower maintenance costs.

OCuSOFT®’s President and COO, Patrick Ward, stated “Initially, Zytaze® was available through physicians only but because of the overwhelming response from patients, we are extending availability directly to patients by offering it online.

Troy Smith, OCuSOFT®’s Vice President, Sales is enthusiastic noting “It’s a win-win for everyone. Patients are seeing better results at a lower cost and physicians are seeing increasing numbers of patients.

For added convenience, ZYTAZE® is now available for purchase online at www.zytaze.com or through your health care professional. For more information, call (800) 233-5469.

    (1)http://www.allure.com/skin-care/2012/11-hottest-
     celebrity-skin-treatments#slide=9
    (2)Koshy JC, Sharabi SE, Feldman EM, Hollier LH, Patrinely JR,
     Soparkar CNS. Effect of dietary zinc and phytase supplementation
     on botulinum toxin treatments. J Drugs Dermatol 2012 Apr 1;
     11(4):507-12.

SOURCE OCuSOFT, Inc.


Source: PR Newswire